《临床指南研究与评价系统Ⅱ》简介

A brief introduction to Appraisal of Guidelines for Research and Evaluation Ⅱ

临床指南在医患临床决策和卫生政策制定时起着重要作用。在指南制定过程中由于方法学和制定策略的不足,导致指南的质量良莠不齐,因此,对指南进行研究和评价具有重要意义。2003年发表的第1版《临床指南研究与评价系统》(Appraisal of Guidelines for Researchand Evaluation,AGREE)对指南的质量保证和成功实施产生了重要作用,目前已得到广泛支持和认同。2009年,AGREE国际协作组织对2003版AGREE修正后制定出新的AGREE即AGREEⅡ。目前,AGREEⅡ已取代2003版AGREE,但国内尚没有AGREEⅡ的相关介绍。本文作者对AGREEⅡ作一介绍,以期其利于指南的研究和评价。

Clinical practice guidelines play an important role in practitioner and patient decisions regarding appropriate clinical health care and in health policy formation. In the guideline development process, inappropriate methodologies and development strategies significantly influence the quality of guidelines; therefore, research and evaluation of guidelines have great significance. The original Appraisal of Guidelines for Research and Evaluation （AGREE） instrument was published in 2003 by a group of international guideline developers and researchers. AGREE has important significance for the quality guarantee and successful implementation of guidelines, and has extensively achieved endorsement since 2003. In 2009, The AGREE Collaboration has developed the AGREE Ⅱ by refining the original AGREE instrument. At present, the AGREE Ⅱ has already replaced the original AGREE instrument; however, related introduction regarding AGREE Ⅱ has not been found in China. The authors of this article briefly introduce the AGREE Ⅱ, and believe that it will add value to research and evaluation of the guidelines.